Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...

New innovations designed to simplify NGS workflows Enhances critical variant identification through improved ...

Researchers are evaluating the P-CARE model, which integrates results from a blended genome-exome sequencing assay and family ...

A growing body of research is pushing cancer science toward a radical shift: detecting and stopping the disease years or even decades before a tumor ever forms. Multiple studies now show that ...

Kathrin Dvir, MD, MSc, discusses how biomarker-driven care, targeted therapies, and evolving sequencing are shaping modern breast cancer treatment.

India's disease burden is undergoing a structural shift. According to the recent data, non-communicable diseases account for ...

When Ivana Goluza Riddell, from NSW, gave birth to her 'happy and healthy' son, her heart swelled with joy. But during a ...

A genetic test developed by researchers at Broad Clinical Labs and the U.S. Department of Veterans Affairs (VA) is now enabling a large, nationwide clinical trial aimed at improving health care for ...

Cells from cancerous tumors can spread, or metastasize, throughout the body. Researchers have long sought to understand what determines where those cells will go and thrive in order to more ...

A Mayo Clinic study published in Journal of Translational Medicine has evaluated the use of genomic testing broadly for rare diseases. With the increased use of genomic testing such as multi-gene ...

Overall, treatment of metastatic triple-positive breast cancer is shifting toward precision-driven regimens that combine HER2 blockade with endocrine and targeted agents tailored to disease burden, ...

Background: Colorectal cancer (CRC) shows significant inter-population heterogeneity in its genomic landscape, yet Middle Eastern populations are underrepresented in large-scale sequencing studies.